Medochemie Limited
Medochemie Limited, headquartered in Cyprus, is a prominent player in the pharmaceutical industry, specialising in the development, manufacturing, and marketing of high-quality generic and branded medications. Founded in 1976, the company has established a strong presence across Europe, Asia, and Africa, with a commitment to enhancing global health through accessible healthcare solutions. With a diverse portfolio that includes a wide range of therapeutic areas, Medochemie is recognised for its innovative approach to drug formulation and delivery. The company’s core products encompass both prescription and over-the-counter medications, distinguished by their rigorous quality standards and affordability. Medochemie's dedication to research and development has positioned it as a trusted partner in the healthcare sector, contributing to its reputation as a leader in the pharmaceutical market.
DitchCarbon Score
How does Medochemie Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medochemie Limited's score of 17 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medochemie Limited's reported carbon emissions
Medochemie Limited, headquartered in Cyprus (CY), currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not disclosed. While there are no documented reduction targets or climate pledges from the company, it is essential to note that many organisations in the pharmaceutical industry are increasingly committing to sustainability and carbon reduction initiatives. Medochemie Limited may be engaging in similar efforts, although specific details are not provided. In the absence of concrete emissions data or commitments, it is crucial for stakeholders to monitor the company's future sustainability strategies and potential climate action plans.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Medochemie Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
